Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Bogdanovic

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Biochemical and Biophysical Research Communications|January 29, 1986
New evidence that the antiestrogen binding site may be a novel growth-promoting histamine receptor (?H3) which mediates the antiestrogenic and antiproliferative effects of tamoxifenL J Brandes, R P Bogdanovic
Biochemical and Biophysical Research Communications|March 16, 1990
Does intracellular histamine mediate mast cell histamine release?L J Brandes, B Sukhu, R P Bogdanovic
Biochemical and Biophysical Research Communications|January 31, 1985
Evidence that the antiestrogen binding site is a histamine or histamine-like receptorL J Brandes, L M Macdonald, R P Bogdanovic
Cancer Chemotherapy and Pharmacology|January 1, 1986
The antiproliferative properties of tamoxifen and phenothiazines may be mediated by a unique histamine receptor (?H3) distinct from the calmodulin-binding siteL J Brandes, R P Bogdanovic, M D Cawker, et al.
Cancer Research|August 1, 1987
Histamine and growth: interaction of antiestrogen binding site ligands with a novel histamine site that may be associated with calcium channelsL J Brandes, R P Bogdanovic, M D Cawker, et al.
Biochemical and Biophysical Research Communications|April 30, 1992
Intracellular histamine and liver regeneration: high affinity binding of histamine to chromatin, low affinity binding to matrix, and depletion of a nuclear storage pool following partial hepatectomyL J Brandes, R P Bogdanovic, J Tong, et al.
Agents and Actions. Supplements|January 1, 1991
The antiproliferative potency of histamine antagonists correlates with inhibition of binding of [3H]-histamine to novel intracellular receptors (HIC) in microsomal and nuclear fractions of rat liverL J Brandes, J R Davie, F Paraskevas, et al.
Cancer Research|July 15, 1988
Correlation of the antiproliferative action of diphenylmethane-derivative antiestrogen binding site ligands with antagonism of histamine binding but not of protein kinase C-mediated phosphorylationL J Brandes, J M Gerrard, R P Bogdanovic, et al.
Cancer Research|July 1, 1992
Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant dosesL J Brandes, R J Arron, R P Bogdanovic, et al.
Journal of the National Cancer Institute|May 18, 1994
Enhanced cancer growth in mice administered daily human-equivalent doses of some H1-antihistamines: predictive in vitro correlatesL J Brandes, R C Warrington, R J Arron, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Biochemical and Biophysical Research Communications|January 29, 1986
New evidence that the antiestrogen binding site may be a novel growth-promoting histamine receptor (?H3) which mediates the antiestrogenic and antiproliferative effects of tamoxifenL J Brandes, R P Bogdanovic
Biochemical and Biophysical Research Communications|March 16, 1990
Does intracellular histamine mediate mast cell histamine release?L J Brandes, B Sukhu, R P Bogdanovic
Biochemical and Biophysical Research Communications|January 31, 1985
Evidence that the antiestrogen binding site is a histamine or histamine-like receptorL J Brandes, L M Macdonald, R P Bogdanovic
Cancer Chemotherapy and Pharmacology|January 1, 1986
The antiproliferative properties of tamoxifen and phenothiazines may be mediated by a unique histamine receptor (?H3) distinct from the calmodulin-binding siteL J Brandes, R P Bogdanovic, M D Cawker, et al.
Cancer Research|August 1, 1987
Histamine and growth: interaction of antiestrogen binding site ligands with a novel histamine site that may be associated with calcium channelsL J Brandes, R P Bogdanovic, M D Cawker, et al.
Biochemical and Biophysical Research Communications|April 30, 1992
Intracellular histamine and liver regeneration: high affinity binding of histamine to chromatin, low affinity binding to matrix, and depletion of a nuclear storage pool following partial hepatectomyL J Brandes, R P Bogdanovic, J Tong, et al.
Agents and Actions. Supplements|January 1, 1991
The antiproliferative potency of histamine antagonists correlates with inhibition of binding of [3H]-histamine to novel intracellular receptors (HIC) in microsomal and nuclear fractions of rat liverL J Brandes, J R Davie, F Paraskevas, et al.
Cancer Research|July 15, 1988
Correlation of the antiproliferative action of diphenylmethane-derivative antiestrogen binding site ligands with antagonism of histamine binding but not of protein kinase C-mediated phosphorylationL J Brandes, J M Gerrard, R P Bogdanovic, et al.
Cancer Research|July 1, 1992
Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant dosesL J Brandes, R J Arron, R P Bogdanovic, et al.
Journal of the National Cancer Institute|May 18, 1994
Enhanced cancer growth in mice administered daily human-equivalent doses of some H1-antihistamines: predictive in vitro correlatesL J Brandes, R C Warrington, R J Arron, et al.
Pageof 1